Inflammation and Immunity
Inflammation and Immunity is a high priority medical field of growing importance both nationally and internationally. The Inflammation and Immunity Core Strategic Theme is one of Imperial College London’s areas of major medical research expertise. Due to the considerable strength and diversity of its research in inflammation and immunity, Imperial College is a national and international leader in this field.
Current research projects include various aspects of: rheumatology (for example rheumatoid arthritis), respiratory disease (for example asthma) and skin conditions (such as psoriasis).
Recent achievements include the discovery of anti-tumour necrosis factor therapy as an effective treatment for rheumatoid arthritis and related diseases.
The Inflammation and Immunity Research Theme benefits from a synergistic relationship with the closely related Strategic Research Theme, Infection.
Strategic Theme Leader for Inflammation and Immunity: Professor Philip Ashton-Rickardt
The HTLV-I genome accumulates at the cell-cell junction and is then transferred to an uninfected cell (Igakura et al (2003) Science 299: 1713-1716).